Non-alcoholic Steatohepatitis
📧 Sign up to get email alerts when something new happens for Non-alcoholic Steatohepatitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-02-23Clinical Trial Update: Phase 1 Study to Evaluate Safety of GR-MD-02 in Subjects With Non-Alcoholic Steatohepatitis (NASH) and Advanced Fibrosis [Phase 1]
Phase 1 study completed to evaluate the safety of GR-MD-02 in subjects with non-alcoholic steatohepatitis (NASH).
-
CLINICAL_TRIALS trial_result · 2015-02-10Clinical Trial Update: Anti-fatigue Effect of Korean Red Ginseng in Patients With Non-alcoholic Hepatitis [Phase 4]
Phase 4 trial evaluating anti-fatigue effects of Korean Red Ginseng in patients with non-alcoholic fatty liver disease has completed, with r…
-
CLINICAL_TRIALS trial_result · 2014-12-18Clinical Trial Update: Ezetimibe Versus Placebo in the Treatment of Non-alcoholic Steatohepatitis [Phase 2]
Phase 2 trial comparing ezetimibe to placebo in non-alcoholic steatohepatitis has completed with results posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-11-20Clinical Trial Update: Double-Blind, Placebo-Controlled Study of Two Doses of EPA-E in Patients With Non Alcoholic Steatohepatitis (NASH) [Phase 2]
This Phase 2 double-blind, placebo-controlled trial evaluated two doses of EPA-E in patients with non-alcoholic steatohepatitis (NASH); resu…
-
CLINICAL_TRIALS trial_result · 2014-08-20Clinical Trial Update: Effects of Siliphos-Selenium-Methionine-Alpha Lipoic Acid in Patients With Fatty Liver and Non-alcoholic Steatohepatitis [Phase 4]
Phase 4 trial evaluating a combination of Siliphos selenium, methionine, and alpha-lipoic acid in fatty liver disease and non-alcoholic stea…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-08-18Clinical Trial Update: Beta Glucosylceramide for Treatment of NASH [Phase 1, Phase 2]
Phase 1/2 trial evaluating Beta Glucosylceramide for non-alcoholic steatohepatitis has completed, with results posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-01-31Clinical Trial Update: A Preliminary Study to Evaluate Cysteamine Therapy in Human Subjects With Non-Alcoholic Steatohepatitis (NASH) [Phase 1, Phase 2]
A Phase 1/2 study evaluated cysteamine therapy in humans with non-alcoholic steatohepatitis (fatty liver). The trial is completed with resul…
-
CLINICAL_TRIALS trial_result · 2013-09-26Clinical Trial Update: Lifestyle Versus Ezetimibe Plus Lifestyle in Patients With Non-alcoholic Steatohepatitis [Phase 4]
Phase 4 trial comparing lifestyle modification alone versus lifestyle modification plus ezetimibe in patients with non-alcoholic steatohepat…
-
CLINICAL_TRIALS trial_result · 2013-03-21Clinical Trial Update: A Proof-of-principle Study of Oral Treatment of Non-alcoholic Steatohepatitis With a Novel PDE4 Inhibitor ASP9831 [Phase 2]
A Phase 2 proof-of-principle trial evaluating the PDE4 inhibitor ASP9831 for non-alcoholic steatohepatitis has completed.
-
CLINICAL_TRIALS trial_result · 2013-02-05Clinical Trial Update: The Effect of Protandim on Non-alcoholic Steatohepatitis [NA]
A completed clinical trial evaluated Protandim for non-alcoholic steatohepatitis, sponsored by the University of Colorado, Denver.
-
CLINICAL_TRIALS trial_result · 2013-01-04Clinical Trial Update: Intragastric Balloon for Treatment of Non Alcoholic Steatohepatitis (NASH) [NA]
A clinical trial evaluating an intragastric balloon for the treatment of non-alcoholic steatohepatitis has completed (NCT01761370).
-
CLINICAL_TRIALS trial_result · 2012-07-20Clinical Trial Update: The Impact of Deferasirox on Non-Alcoholic-Steatohepatitis [Phase 1, Phase 2]
A Phase 1/2 trial evaluating the iron chelator deferasirox in non-alcoholic steatohepatitis with abnormal iron storage, which has completed.
-
CLINICAL_TRIALS trial_result · 2012-06-21Clinical Trial Update: Effect on Liver Histology of Vitamin D in Patients With Non-alcoholic Steatohepatitis [Phase 3]
A Phase 3 clinical trial update evaluating the effect of Vitamin D on liver histology in patients with non-alcoholic steatohepatitis (a form…
-
CLINICAL_TRIALS trial_result · 2011-08-19Clinical Trial Update: Effects of Rosiglitazone and Alpha-lipoic Acid on the Patients With Pathologically Proved NASH [Phase 4]
Phase 4 clinical trial evaluating rosiglitazone and alpha-lipoic acid in pathologically proven non-alcoholic steatohepatitis has been termin…
-
CLINICAL_TRIALS trial_result · 2011-05-17Clinical Trial Update: A Potential Novel Marker for Liver Fibrosis in NASH: the Soluble Secreted Form of the Human Asialoglycoprotein Receptor
A completed clinical trial evaluated the soluble secreted form of the human asialoglycoprotein receptor as a potential biomarker for liver f…
-
CLINICAL_TRIALS trial_result · 2010-11-08Clinical Trial Update: Eltrombopag To Reduce The Need For Platelet Transfusion In Subjects With Chronic Liver Disease And Thrombocytopenia Undergoing Elective Invasive Procedures [Phase 3]
Phase 3 trial investigating eltrombopag to reduce platelet transfusions in patients with chronic liver disease and thrombocytopenia undergoi…
-
CLINICAL_TRIALS trial_result · 2009-08-13Clinical Trial Update: Phase 1 Pharmacokinetic Study Of CP-945598 In Patients With NASH [Phase 1]
Pfizer’s Phase 1 pharmacokinetic study of CP-945598 in patients with Non-Alcoholic Steatohepatitis has completed.
-
CLINICAL_TRIALS trial_result · 2009-02-03Clinical Trial Update: Pilot Study of Ursodesoxycholic Acid in Non-Alcoholic Steatohepatitis [Phase 2]
Phase 2 pilot study of Ursodeoxycholic acid in non-alcoholic steatohepatitis has completed, evaluating serum ALT levels and serum markers fo…
-
CLINICAL_TRIALS trial_result · 2009-01-21Clinical Trial Update: S-Adenosylmethionine Therapy for Non-Alcoholic Steatohepatitis [Phase 3]
Phase 3 clinical trial evaluating S-adenosylmethionine for non-alcoholic steatohepatitis has completed, with a status update from the sponso…
-
CLINICAL_TRIALS trial_result · 2007-06-27Clinical Trial Update: A One-Year, Randomized, Double-Blind, Placebo-Controlled Trial of Rosiglitazone in Non-Alcoholic Steatohepatitis [Phase 2]
This document notes the completion of a Phase 2 randomized, double-blind, placebo-controlled trial evaluating rosiglitazone for non-alcoholi…